Amp Continues to Add ARRY to its Portfolio This Week

Ahead of its presentations at the European Society for Medical Oncology (ESMO) annual meeting this week, Amp added a stake in Array Biopharma (ARRY) to its hypothetical fund earlier in the week, and is increasing that stake today.

*Disclaimer: Information provided on and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon